Clinical Trials Browser

Phase 1/2 × INDUSTRY × lorvotuzumab mertansine × Clear all

NCT00065429 2012-07-18

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Phase 1/2 Completed

64 enrolled 13 charts

Small Cell Lung Carcinoma